
FDA Approves Acoltremon Ophthalmic Solution for Dry Eye Disease
The FDA approved acoltremon ophthalmic solution (Tryptyr, formerly AR-15512) 0.003% for the treatment of dry eye disease (DED). The new approval is for a first-in-class TRPM8 receptor agonist to stimulate corneal sensory nerves to increase natural tear …